Efficacy and safety of omalizumab in an Asian population with moderate-to-severe persistent asthma.

Arihiko Kanehiro

Research output: Contribution to journalArticle

54 Citations (Scopus)
Original languageEnglish
Pages (from-to)1156-1165
Number of pages10
JournalRespirology
Volume14
Publication statusPublished - 2009

Cite this